Advances in the study of HLA class Ib in maternal-fetal immune tolerance.

Yang, Yiran; Wang, Wanning; Weng, Jing; Li, Huifang; Ma, Yanmin; Liu, Lingyan; Ma, Wei

Yang, Yiran; Wang, Wanning; Weng, Jing; Li, Huifang; Ma, Yanmin; Liu, Lingyan; Ma, Wei.

Afiliação

Yang Y; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, School of Pharmaceutical Sciences, Capital Medical University, Beijing, China.
Wang W; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, School of Pharmaceutical Sciences, Capital Medical University, Beijing, China.
Weng J; School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Li H; School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Ma Y; Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.
Liu L; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, School of Pharmaceutical Sciences, Capital Medical University, Beijing, China.
Ma W; School of Basic Medical Sciences, Capital Medical University, Beijing, China.

Front Immunol ; 13: 976289, 2022.

Article em En | MEDLINE | ID: mdl-36105800

Assuntos

Feto; Antígenos HLA-G; Família; Antígenos HLA-G/genética; Antígenos HLA-G/metabolismo; Humanos; Tolerância Imunológica; Trofoblastos/metabolismo

Palavras-chave

HLA class Ib; HLA-G, HLA-E, HLA-F; decidual immune cells; maternal-fetal immune tolerance; pregnancy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feto / Antígenos HLA-G Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google